Prenatal diagnostic strategies applied today are based mainly on polymerase chain reaction (PCR) analytical protocols. In Greece a wide range of mutations underlie the thalassaemic haemoglobinopathies, and consequently a variety of PCR-based methods are required to facilitate diagnosis of all potential abnormal genotypes. PCR protocols include those which are relatively simple and others that are technically challenging, but very few have been designed for high through-put clinical diagnostics. Over a period of 18 months we carried out prenatal diagnosis in 147 pregnancies (150 fetal samples) at risk for a wide range of haemoglobinopathies. This involved the precise characterization of parental genotypes and the subsequent analysis of fetal DNA samples. In this series, 18 different mutations in the α-or β-globin clusters were identified. For the characterization of these mutations, five PCR-based protocols were selected: denaturing gradient gel electrophoresis (DGGE), amplification refractory mutation system (ARMS) PCR, restriction endonuclease analysis of PCR fragments, oligonucleotide hybridization and 'gap' PCR for detection of deletions. To avoid spurious diagnosis due to contamination of fetal samples, two additional methods were used to genotype polymorphic variable nucleotide tandem repeat (VNTR) regions of the genome in parental and fetal samples. Through analysis of the results we assess the advantages and drawbacks of the selected PCR-based protocols for providing routine clinical diagnostics.
Introduction
To facilitate diagnosis of all potential pathological genotypes, a variety of DNA analytical methods are required. PCR-based The aim of prenatal diagnosis is to provide an accurate and protocols include those that are relatively simple and others rapid result as early in the pregnancy as possible. Prenatal that are technically challenging. However, few have been diagnosis for thalassaemia and related haemoglobinopathies developed for high through-put diagnostics. was initially applied over 20 years ago through analysis at the In this report we describe the protocols that we applied, protein level (Clegg et al., 1966; Weatherall and Clegg, 1981) .
over a period of~18 months, to diagnose 150 fetal samples As recombinant DNA technology evolved, DNA analysis became feasible (Kan et al., 1976; Kan and Dozy, 1978;  Orkin at risk for a wide range of haemoglobinopathies. This involved et al., 1978) but prenatal diagnosis was not widely applicable, the characterization of 18 different pathological mutations in partly because available methods were cumbersome and time the α-and β-globin gene clusters with the application of consuming, and partly because knowledge of the molecular five different PCR-based methods [denaturing gradient gel basis of these disorders was limited. The discovery of the electrophoresis (DGGE), amplification refractory mutation syspolymerase chain reaction (PCR) in the mid 1980s (Mullis tem (ARMS) PCR, restriction endonuclease analysis of PCR et al., 1986) led to the development of numerous methods products, oligonucleotide hybridization and 'gap' PCR for for mutation analysis and subsequently to an explosion of detection of deletions] and in addition the monitoring of fetal information relative to the molecular genetics of the haemosample contamination. In the light of our results we assess the globinopathies. This information and many PCR-based analytadvantages and disadvantages of these PCR-based protocols ical protocols form the basis of prenatal diagnostic strategies and the optimization of advanced DNA analytical methodology today.
as applied to high through-put medical diagnostics. In Greece, α-and β-thalassaemia each have a carrier incidence of~8%, but it is the clinically more severe β-thalassaemias and related haemoglobinopathies which consti-
Materials and methods
tute the major requirement for prenatal diagnosis. More than The molecular diagnosis of 150 fetal samples (including three 20 pathological mutations in the β-globin gene cluster twin pregnancies) at risk for haemoglobinopathies involved the (Kattamis et al., 1990; Traeger-Synodinos et al., 1996) and haematological diagnosis and molecular characterization of all hetero-11·α-thalassaemia mutations have been observed in the Greek zygote parents (not presented) and the subsequent genotyping of fetal population (Kanavakis et al., 1986; Traeger-Synodinos et al., material in each case. Of the 150 prenatal samples analysed, 105 were trophoblast samples and 45 were amniotic fluid samples.
1993).
Each couple requesting prenatal diagnosis was counselled either sizing of products by agarose gel electrophoresis. Results were always assessed in comparison with positive and negative controls for the before initiation of pregnancy or as early as possible in the pregnancy, at which time blood samples were taken to confirm the haematological mutation analysed simultaneously.
Restriction enzyme digestion analysis of the β-gene cluster diallelic diagnosis and as a source of DNA for mutation analysis; the latter was essential before proceeding to fetal DNA analysis. Referral to a polymorphic sites (Orkin et al., 1982 ) was based on previously described PCR protocols (Sutton et al., 1989; Old et al., 1990) . gynaecologist determined an appropriate date for fetal sample biopsy.
Allele-specific oligonucleotide (ASO) hybridization

Fetal sample preparation
Radioactively labelled allele-specific oligonuleotides (ASOs) were Fetal sampling protocols included the biopsy of chorionic villi (CVS; hybridized to α-or β-globin gene PCR products immobilized on trophoblast) at 10-12 weeks of pregnancy or amniocentesis from Nylon filters (Amersham Life Science) by Southern blot alkali transfer 14-20 weeks.
as previously described (Traeger-Synodinos et al., 1993 ; Tzetis et al., On receipt of a trophoblast sample, the villi were viewed under a 1994). Positive hybridization was detected by autoradiography under microscope (ϫ10 magnification) and carefully separated from any standard conditions and results were always judged in comparison tissue that was of doubtful origin, placed in 1 ml of TE buffer (10 with positive and negative controls for the mutation. mM Tris, pH7; 1mM EDTA ) in sterile 1.5 ml Eppendorf tubes and PCR detection of deletions ('gap' PCR) washed twice prior to further processing.
Amongst the prenatal samples, it was necessary to investigate the Amniotic cells were processed directly without culturing. The presence of two δβ-thalassaemia deletions. The Sicilian-δβ, and amniotic fluid samples (usually not more than 15 ml total volume) Corfu-δβ, deletions were detected by previously described methods were transferred to sterile tubes and centrifuged to collect the cell (Galanello et al., 1990; Craig et al., 1994) . pellet at 2500 g for 15 min in a bench centrifuge. The cell pellet was then transferred to 1.5 ml sterile eppendorf tubes and washed twice Assessment of maternal DNA contamination with TE before further processing.
Haplotyping of the variable number of tandem repeat (VNTR) region The fetal samples were either subjected to extraction with phenol-3Ј to the ApoB gene on chromosome 2 was achieved by a PCR chloroform using a standard protocol (Old and Higgs, 1982) scaled reaction followed by sizing of PCR products using agarose gel down to micro volumes, or lysed by boiling for 2 min in 0.1 M electrophoresis (Decorte et al., 1990 ). An alternative protocol included NaOH/2 M NaCl (Kazazian, 1989) .
haplotyping of microsatellite sites in the CFTR gene (Morral and Estivill, 1992) . In all prenatal samples, parental and fetal samples Mutation analysis were haplotyped simultaneously to exclude maternal contamination The DNA diagnostic methods applied included those that directly (and non-paternity). characterize pathological mutations and those for indirect genotyping. In all prenatal samples, parental mutations were characterized prior to fetal DNA analysis and all fetal samples were subsequently assayed 5Ј-CAACTTCATCCACGTTCACC-3Ј C:
5Ј-AGCACACAGACCAGCACGTT-3Ј I:
5Ј-AACGTGCTGGTCTGTGTGCT-3Ј J:
5Ј-AAATGCACTGACCTCCCACA-3Ј (GC) indicates that a 45 bp GC-clamp was attached at the 5Ј end of the primer for DGGE analysis. 
ARMS ϭ amplification refractory mutation system; DGGE ϭ denaturing gradient gel electrophoresis; ASO ϭ allele-specific oligonucleotide hybridization. a Parent was compound heterozygote for βIVSI-110 and HbO-Arab. The couple was counselled accordingly. b Parental sample was referred as HbS heterozygote. DNA analysis diagnosed the parent as HbD-Punjab and the couple was counselled accordingly.
described in the methodology to genotype each parental, and However, certain areas of the β-globin gene include polymorphic nucleotide changes which may confuse assessment subsequently each fetal sample.
DGGE was the primary method used for screening the β-of DGGE analysis and all results needed careful interpretation; a DGGE pattern alone was never considered a definitive globin gene in the heterozygous parents (Figure 2 ) to localize the pathological mutations. Most β-gene mutations are associdiagnosis for a pathological mutation in parental samples. DGGE analysis was successfully applied to genotype 104 ated with distinct electrophoretic patterns, thus directing the choice of method for specifically characterizing the mutation. fetal samples. All fetal genotype results obtained by DGGE were unambivalent and consistent with the diagnosis by other The ARMS method was standardized in our laboratory for β0IVSI-1 (GϾA) 5 2.0 the characterization of the nine common Greek β-thalassaemia βϩIVSI-6 (TϾC) 15 3.0 β0codon 39 (CϾT) 2.5 2.5 mutations (Table I) the nine most common β-thalassaemia mutations are summarized in Table II . It was observed that batch-to-batch variation a The recommended primer concentrations (Old et al., 1990) were modified to achieve mutation-specific amplification. quality of results obtained and restandardization of the PCR conditions was occasionally required. Of the 138 prenatal samples analysed with ARMS, there were only two cases which gave ambivalent results. Both were phenol extracted Restriction endonuclease (RE) analysis was applicable for the characterization of eight β-globin gene mutations observed trophoblast samples under investigation for different β-thalassaemia mutations, and in each cases repeat ARMS PCR in 62 of the pathological alleles in the parents (Table I) . The presence or complete absence of a mutation was clearly reactions gave a conflicting mutation-specific PCR product. In all other cases the genotype result from the ARMS was distinguished by RE analysis in all cases. However, for the mutations β 0 codon 6(-A), β 0 codon 5(-CT) and HbS, which consistent with the other methods used for the diagnosis. However, amongst 28 prenatal samples in which both parents all destroy a cutting site for the restriction enzyme DdeI, the definitive presence of a normal allele was not always clearly were carriers of an identical mutation, ARMS PCR using the primers specific for the wild-type allele often gave a faint distinguished when genotyping the fetuses of parents that were carriers for the same mutation (five cases: four for HbS and product in the homozygous mutant control samples set up in parallel to the sample under investigation. Due to difficulties one for β 0 codon 5-CT) and an alternative method was applied. The hybridization of radioactively labelled allele specific found in routinely standardizing total refractivity of most normal ARMS primers to mutant alleles, we preferred to use oligonucleotides was used to characterize at least one mutation in 22 of the prenatal samples. Five of these included genotypes alternative methods for genotype confirmation in prenatal samples in which both parents carried the same mutation.
with no alternative method for characterization (Table I ) and in 17 samples it was used as the second confirmatory method included DGGE, ARMS PCR, restriction endonuclease analysis, ASO hybridization and 'gap' PCR. for the genotype.
DGGE was the primary method of choice, localizing 'Gap' PCR was used in four prenatal samples to investigate the pathological mutation within the β-globin gene in β-the presence of the Sicilian δβ-thalassaemia deletion chromothalassaemia heterozygotes and genotyping fetal samples once some and in four samples to investigate the δβCorfu deletion parental mutations were established. However, DGGE is techwith clear results in all cases.
nically very challenging. It requires sophisticated equipment Linkage analysis in the β-globin gene cluster was appropriate and is subject to many causes for methodological failure, in 15 families with a previous child. In two cases, which were including the batch quality of all chemical components of the only 50% informative relative to the β-globin gene mutations, gels, buffer, PCR primers and gel running conditions. This it enabled 100% genotyping of the fetus and in 13 cases, must be taken into consideration when selecting protocols for linkage was used to confirm the genotype based on mutation a routine diagnostic service. analysis. The assessment of maternal contamination was carried ARMS PCR was the other primary method applied for out in most cases in which the fetus was identified to carry at analysing β-thalassaemia mutations in our laboratory. It is a least the mother's pathological mutation, i.e. in 32 prenatal direct mutation detection method and is extremely rapid, samples from amniotic fluid cells and in 65 from chorionic producing results within a few hours of PCR set-up by villi. In 23 cases the 3ЈApoB VNTR haplotypes were nonsimply analysing the amplification products using agarose gel informative and alternative polymorphic markers in the CFTR electrophoresis. It proved to be extremely reliable in almost gene were used. In two trophoblast samples the ambivalent all prenatal cases, although we found it difficult to standardize tissue morphology was supported by identical fetal and for differentiating between heterozygous or homozygous genomaternal VNTR genotypes and repeat sampling was requested.
types for a single pathological mutation. There was no evidence of maternal contamination in any of
Restriction endonuclease analysis was used as a secondary the amniocentesis samples.
method. For direct mutation analysis it is simple but limited to specific mutations. Linkage analysis using diallelic polymorphic restriction sites also has limited application, since
Discussion
DNA genotyping in additional family members is necessary Until long-term curative therapy becomes a feasible option for in order to establish linkage and several polymorphic sites treating genetic disorders, prenatal diagnosis for avoiding the may have to be analysed to find those that are informative. birth of affected individuals is the main approach to controlling
The hybridization of radioactively labelled allele-specific such diseases and has become an accepted procedure in oligonucleotides (ASOs) was standardized for the characterizamost populations world-wide. In this study only one affected tion of all pathological α-and β-globin gene mutations pregnancy was not terminated, and even in the three cases described in the Greek population. The method was found to based on 50% informativity which were all positive for the be simple and reliable when results were judged in comparison known mutation, the pregnancies were terminated.
with known positive and negative controls. However, because In Greece, the thalassaemia syndromes and haemoglobinthe ASO probes were radioactively labelled in the protocol opathies are extremely heterogeneous both at the molecular and established in our unit, it was only applied when all other consequently phenotypic level. To offer a prenatal diagnostic methods had failed or were unavailable for the particular service through DNA analysis it is essential that parents have mutation under investigation, thus avoiding the use of radiocorrect haematological diagnosis (hence the necessity of close activity which is hazardous for the operator and expensive. collaboration with a specialized haematology laboratory), and
The principle of 'gap' PCR is that PCR primers located far that the DNA diagnostic laboratory has several standardized apart in native DNA are unable to direct amplification unless analytical techniques.
an intervening genomic DNA deletion brings them in to closer The aim of prenatal diagnosis is to provide an accurate and proximity. Although the PCR based detection of deletions was rapid result as early in the pregnancy as possible. Until only applicable in a few prenatal samples, it was consistently preimplantation diagnostic protocols have been optimized reliable in all cases and provided results within a few hours. (Thornhill et al., 1994; Findlay et al., 1995) , a prerequisite Finally, the extreme sensitivity of PCR introduces the involves obtaining fetal material promptly and safely. With possibility of contamination and false results. Even when present protocols, trophoblast samples can be obtained at 8-general precautions are taken to avoid contamination from 10 weeks of gestation (Froster and Jackson, 1996) . If CVS sources in the laboratory, minimal quantities of maternal cells sampling is not an option for the pregnancy in question, then in the fetal sample could produce a spurious diagnosis. To we have observed that satisfactory quantities of amniotic fluid exclude this possibility, polymorphic regions of the genome cells for PCR analysis are obtained through amniocentesis were analysed in both parents and fetal samples, particularly from as early as 14 weeks of pregnancy.
in those cases in which the fetus was identified to carry at For the preparation of genetic material from fetal samples least the mother's mutation. The sizing of the VNTR 3Ј to the both the phenol extraction method and the alkali lysis protocol ApoB gene involved a simple protocol but was not always were effective but the latter was simpler and faster, preparing informative and it was necessary to have an alternative protocol a sample ready for PCR set-up within 20 min.
established in the laboratory.
In conclusion, substantial advances have been made in the The DNA analytical methods chosen in our laboratory
